World's Best Scientists 2026 revealed!
Carsten Bokemeyer

Carsten Bokemeyer

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 132 2304 2146 113 109 1308 70304

Carsten Bokemeyer publications per year

The chart shows the history of publications by Carsten Bokemeyer between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Carsten Bokemeyer published across 39 years, from 1987 to 2025, averaging 40.3 papers a year. Output peaked at 123 publications in 2023. 139 of the 1,570 publications appeared in the last two years.

No. of publications
25 50 75 100
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 123. Peak 123 publications in 2023. 1987: 1 publication 1988: 0 publications 1989: 0 publications 1990: 2 publications 1991: 2 publications 1992: 8 publications 1993: 26 publications 1994: 16 publications 1995: 23 publications 1996: 22 publications 1997: 29 publications 1998: 25 publications 1999: 25 publications 2000: 15 publications 2001: 23 publications 2002: 14 publications 2003: 27 publications 2004: 30 publications 2005: 37 publications 2006: 41 publications 2007: 43 publications 2008: 63 publications 2009: 57 publications 2010: 79 publications 2011: 63 publications 2012: 77 publications 2013: 53 publications 2014: 54 publications 2015: 51 publications 2016: 55 publications 2017: 51 publications 2018: 36 publications 2019: 46 publications 2020: 63 publications 2021: 80 publications 2022: 71 publications 2023: 123 publications 2024: 62 publications 2025: 77 publications
1987 2025

1,570 publications in total across all disciplines

View publications per year as a table
Carsten Bokemeyer: publications per year, 1987 to 2025
Year Publications
1987 1
1988 0
1989 0
1990 2
1991 2
1992 8
1993 26
1994 16
1995 23
1996 22
1997 29
1998 25
1999 25
2000 15
2001 23
2002 14
2003 27
2004 30
2005 37
2006 41
2007 43
2008 63
2009 57
2010 79
2011 63
2012 77
2013 53
2014 54
2015 51
2016 55
2017 51
2018 36
2019 46
2020 63
2021 80
2022 71
2023 123
2024 62
2025 77
Total 1,570
Download as CSV

Carsten Bokemeyer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carsten Bokemeyer sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,301–1,320 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,308 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28 1,308
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Carsten Bokemeyer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carsten Bokemeyer sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 132–133 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 132 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168 132
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Carsten Bokemeyer is affiliated with Universität Hamburg in Germany. Their research activities are primarily focused within the field of Medicine, with significant specialization in areas such as Oncology, Molecular Biology, Hematology, Pulmonary and Respiratory Medicine, and Surgery.

The scientist has contributed extensively to topics including:

  • Colorectal Cancer Treatments and Studies
  • Testicular diseases and treatments
  • Multiple Myeloma Research and Treatments
  • Palliative Care and End-of-Life Issues
  • Cancer survivorship and care
  • Childhood Cancer Survivors' Quality of Life
  • Lung Cancer Treatments and Mutations

Frequent coauthors associated with Carsten Bokemeyer's publications include:

  • Walter Fiedler
  • Katja Weisel
  • Karin Oechsle
  • Gunhild von Amsberg
  • Winfried Alsdorf

Their research has been published in a variety of scientific journals, with a notable record in:

  • Journal of Clinical Oncology
  • Cancers
  • Hämostaseologie
  • Annals of Oncology
  • BMC Palliative Care

Among their recent papers are:

  • "Autopsy Findings and Venous Thromboembolism in Patients With COVID-19," 2020, Annals of Internal Medicine
  • "Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer," 2023, Nature
  • "Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium," 2021, Journal of Clinical Oncology
  • "CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial," 2023, Nature Medicine
  • "Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up," 2022, Annals of Oncology

Best Publications

  • Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

    Jan B. Vermorken;Ricard Mesia;Fernando Rivera;Eva Remenar

  • Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.

    Dominic Wichmann;Jan-Peter Sperhake;Marc Lütgehetmann;Stefan Steurer

  • Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

    Carsten Bokemeyer;Igor Bondarenko;Anatoly Makhson;Joerg T. Hartmann

  • Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

    Michael Pfreundschuh;Joerg Schubert;Marita Ziepert;Rudolf Schmits

  • The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

    Heinz Ludwig;Simon Van Belle;Peter Barrett-Lee;Gunnar Birgegård

  • Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

    Andreas Engert;Annette Plütschow;Hans Theodor Eich;Andreas Lohri

  • Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

    C. Bokemeyer;I. Bondarenko;J. T. Hartmann;F. de Braud

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials.

    Carsten Bokemeyer;Eric Van Cutsem;Philippe Rougier;Fortunato Ciardiello

  • EAU Guidelines on testicular cancer, 2011 update

    P. Albers;W. Albrecht;F. Algaba;C. Bokemeyer

  • Guidelines on Testicular Cancer: 2015 Update.

    Peter Albers;Walter Albrecht;Ferran Algaba;Carsten Bokemeyer

  • European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

    H. J. Schmoll;R. Souchon;S. Krege;P. Albers

  • Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.

    Marcus M. Schittenhelm;Sharon Shiraga;Sharon Shiraga;Arin Schroeder;Arin Schroeder;Amie S. Corbin

  • The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

    Markus M. Heiss;Pawel Murawa;Piotr Koralewski;Elzbieta Kutarska

  • Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

    Carsten Bokemeyer;Craig R. Nichols;Jean P. Droz;Hans J. Schmoll

  • Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

    Eric Van Cutsem;Roberto Labianca;György Bodoky;Carlo Barone

  • Association of KRAS G13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab

    Sabine Tejpar;Ilhan Celik;Michael Schlichting;Ute Sartorius

  • Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

    Matthias Schwab;Ulrich M. Zanger;Claudia Marx;Elke Schaeffeler

  • EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

    C. Bokemeyer;M.S. Aapro;A. Courdi;J. Foubert

  • Testicular germ cell tumours

    Ewa Rajpert-De Meyts;Katherine A McGlynn;Keisei Okamoto;Michael A S Jewett

Frequent Co-Authors

Lothar Kanz
Lothar Kanz University of Tübingen
Ronald Simon
Ronald Simon Universität Hamburg
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Klaus Pantel
Klaus Pantel Universität Hamburg
Hans-Joachim Schmoll
Hans-Joachim Schmoll Martin Luther University Halle-Wittenberg
Jakob R. Izbicki
Jakob R. Izbicki Universität Hamburg
Boris Fehse
Boris Fehse Universität Hamburg
Markus Graefen
Markus Graefen Universität Hamburg
Heinz Ludwig
Heinz Ludwig University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career opportunities beyond traditional medical school is a smart way to diversify your future in healthcare. Today, a wide variety of accredited online programs provide alternative routes to leadership, advanced practice, and specialized roles within the industry.

Those interested in healthcare administration may consider cheap mha programs to develop essential management and leadership skills while maintaining affordability. For nurses seeking advancement, the best online dnp programs can prepare you for top clinical or research positions.

Aspiring pharmacists have access to pharmacy school online accredited options, making it easier to earn a PharmD with flexible, remote study. In addition, those looking to work in health data and records management can benefit from online rhia certification programs online, which open doors to technology-driven careers in healthcare systems.

Directing your education towards these alternative paths can expand your professional options and create a rewarding, in-demand career within the broader healthcare sector.

Best Scientists Citing Carsten Bokemeyer

Trending Scientists

Recently Published Articles